MoonLake Total Assets from 2010 to 2024

MLTX Stock

USD 54.43 0.19 0.35%

MoonLake Immunotherapeuti Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

526.5 M

Current Value

552.9 M

Quarterly Volatility

155.5 M

Credit Downgrade

Yuan Drop

Covid

Check MoonLake Immunotherapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MoonLake Immunotherapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 12.5 K, Other Operating Expenses of 34.1 M or Total Operating Expenses of 34.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.28. MoonLake financial statements analysis is a perfect complement when working with MoonLake Immunotherapeuti Valuation or Volatility modules.

Check out the analysis of MoonLake Immunotherapeuti Correlation against competitors.

Latest MoonLake Immunotherapeuti's Total Assets Growth Pattern

Below is the plot of the Total Assets of MoonLake Immunotherapeutics over the last few years. Total assets refers to the total amount of MoonLake Immunotherapeuti assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in MoonLake Immunotherapeuti books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. MoonLake Immunotherapeuti's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MoonLake Immunotherapeuti's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 526.54 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

MoonLake Total Assets Regression Statistics

	Arithmetic Mean	163,260,391
	Geometric Mean	117,863,977
	Coefficient Of Variation	95.28
	Mean Deviation	100,384,860
	Median	116,633,898
	Standard Deviation	155,548,336
	Sample Variance	24195.3T
	Range	543.2M
	R-Value	0.50
	Mean Square Error	19497.1T
	R-Squared	0.25
	Significance	0.06
	Slope	17,451,111
	Total Sum of Squares	338734T

MoonLake Total Assets History

	2024	552.9 M
	2023	526.5 M
	2022	76.8 M
	2021	9.7 M

Other Fundumenentals of MoonLake Immunotherapeuti

Intangibles To Total Assets

MoonLake Immunotherapeuti Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Accounts Payable	Net Receivables	Deferred Long Term Liab	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Property Plant Equipment	Capital Surpluse	Current Deferred Revenue
Total Assets		1.0	-0.98	-0.75	0.33	0.97	-0.17	-0.51	-0.7	-0.63	0.98	-0.94	0.98	-0.94	-0.74	0.97	0.88	-0.94	0.93
Total Stockholder Equity	1.0		-0.97	-0.71	0.28	0.96	-0.2	-0.47	-0.66	-0.59	0.97	-0.93	0.96	-0.93	-0.7	0.96	0.86	-0.93	0.92
Net Debt	-0.98	-0.97		0.86	-0.49	-1.0	0.01	0.67	0.79	0.73	-1.0	0.93	-1.0	0.93	0.82	-1.0	-0.95	0.93	-0.96
Retained Earnings	-0.75	-0.71	0.86		-0.74	-0.88	-0.28	0.95	0.92	0.9	-0.86	0.78	-0.87	0.78	0.93	-0.88	-0.91	0.78	-0.81
Total Liab	0.33	0.28	-0.49	-0.74		0.51	0.85	-0.87	-0.45	-0.43	0.5	-0.46	0.5	-0.46	-0.46	0.5	0.49	-0.46	0.47
Total Current Assets	0.97	0.96	-1.0	-0.88	0.51		0.01	-0.71	-0.81	-0.75	1.0	-0.94	1.0	-0.94	-0.84	1.0	0.94	-0.94	0.94
Short Term Debt	-0.17	-0.2	0.01	-0.28	0.85	0.01		-0.52	0.05	0.05	0.0	0.0	0.0	0.0	0.04	0.0	-0.02	0.0	0.01
Common Stock	-0.51	-0.47	0.67	0.95	-0.87	-0.71	-0.52		0.82	0.82	-0.68	0.61	-0.68	0.61	0.83	-0.7	-0.75	0.61	-0.62
Net Tangible Assets	-0.7	-0.66	0.79	0.92	-0.45	-0.81	0.05	0.82		0.99	-0.78	0.65	-0.79	0.65	0.99	-0.81	-0.92	0.65	-0.76
Accounts Payable	-0.63	-0.59	0.73	0.9	-0.43	-0.75	0.05	0.82	0.99		-0.71	0.62	-0.72	0.62	0.99	-0.75	-0.85	0.62	-0.67
Net Receivables	0.98	0.97	-1.0	-0.86	0.5	1.0	0.0	-0.68	-0.78	-0.71		-0.95	1.0	-0.95	-0.81	1.0	0.93	-0.95	0.94
Deferred Long Term Liab	-0.94	-0.93	0.93	0.78	-0.46	-0.94	0.0	0.61	0.65	0.62	-0.95		-0.95	1.0	0.74	-0.94	-0.78	1.0	-0.8
Net Invested Capital	0.98	0.96	-1.0	-0.87	0.5	1.0	0.0	-0.68	-0.79	-0.72	1.0	-0.95		-0.95	-0.82	1.0	0.93	-0.95	0.94
Short Long Term Debt	-0.94	-0.93	0.93	0.78	-0.46	-0.94	0.0	0.61	0.65	0.62	-0.95	1.0	-0.95		0.74	-0.94	-0.78	1.0	-0.8
Capital Stock	-0.74	-0.7	0.82	0.93	-0.46	-0.84	0.04	0.83	0.99	0.99	-0.81	0.74	-0.82	0.74		-0.85	-0.9	0.74	-0.75
Net Working Capital	0.97	0.96	-1.0	-0.88	0.5	1.0	0.0	-0.7	-0.81	-0.75	1.0	-0.94	1.0	-0.94	-0.85		0.94	-0.94	0.94
Property Plant Equipment	0.88	0.86	-0.95	-0.91	0.49	0.94	-0.02	-0.75	-0.92	-0.85	0.93	-0.78	0.93	-0.78	-0.9	0.94		-0.78	0.96
Capital Surpluse	-0.94	-0.93	0.93	0.78	-0.46	-0.94	0.0	0.61	0.65	0.62	-0.95	1.0	-0.95	1.0	0.74	-0.94	-0.78		-0.8
Current Deferred Revenue	0.93	0.92	-0.96	-0.81	0.47	0.94	0.01	-0.62	-0.76	-0.67	0.94	-0.8	0.94	-0.8	-0.75	0.94	0.96	-0.8

Click cells to compare fundamentals

About MoonLake Immunotherapeuti Financial Statements

MoonLake Immunotherapeuti investors use historical fundamental indicators, such as MoonLake Immunotherapeuti's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MoonLake Immunotherapeuti. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	526.5 M	552.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for MoonLake Stock Analysis

When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC